Research Reports in Pharmaceuticals

Erectile Dysfunction Drugs Market (2026 - 2033)

The global erectile dysfunction drugs market size was estimated at USD 3.2 billion in 2025 and is projected to grow from USD 3.4 billion in 2026 to USD 6.6 billion by 2033, growing at a CAGR of 9.8% from 2026 to 2033. North America dominated the Erectile Dysfunction Drugs market with the... Read More »

June 2026

Cold Plasma Market (2026 - 2033)

The global cold plasma market size was valued at USD 167.8 million in 2025 and is projected to grow from USD 191.1 million in 2026 to USD 495.9 million by 2033, at a CAGR of 14.6% from 2026 to 2033. This growth is attributed to the overall development of the healthcare industry, which ha... Read More »

June 2026

Dasatinib Market (2026 - 2033)

The global dasatinib market size was valued at USD 5.6 billion in 2025 and is projected to grow from USD 5.7 billion in 2026 to USD 7.6 billion by 2033, at a CAGR of 4.3% from 2026 to 2033. North America dominated the market with the largest revenue share of 54.2% in the global market in 2025. The global dasatinib m... Read More »

June 2026

Amitriptyline Hydrochloride Market (2026 - 2033)

The global amitriptyline hydrochloride market size was valued at USD 381.2 million in 2025 and is projected to grow from USD 393.5 million in 2026 to USD 510.2 million by 2033, at a CAGR of 3.8% from 2026 to 2033. The market in North America dominated with a revenue share of 37.2% in 202... Read More »

June 2026

Ebola Market (2026 - 2033)

The global ebola market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.3 billion in 2026 to USD 2.3 billion by 2033, at a CAGR of 8.3% from 2026 to 2033. The market in North America dominated with a revenue share of 40.9% in 2025. The market is witnessing ... Read More »

June 2026

Exosome-based Therapeutics Market (2026 - 2033)

The global exosome-based therapeutics market size was valued at USD 56.3 million in 2025 and is projected to grow from USD 66.5 million in 2026 to USD 220.2 million by 2033, at a CAGR of 18.7% from 2026 to 2033. The market in North America dominated with a revenue share of 39.5% in 2025.... Read More »

June 2026

Boric Acid Suppository Market (2026 - 2033)

The global boric acid suppository market size was valued at USD 352.1 million in 2025 and is projected to grow from USD 365.0 million in 2026 to USD 485.9 million by 2033, at a CAGR of 4.2% from 2026 to 2033. North America dominated the market with the largest revenue share of 35.4% in the global market in 2025. The... Read More »

June 2026

Inhalation Anesthesia Market (2026 - 2033)

The global inhalation anesthesia market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.0 billion in 2026 to USD 3.9 billion by 2033, at a CAGR of 9.7% from 2026 to 2033. North America dominated the inhalation anesthesia market with the largest revenue shar... Read More »

June 2026

Pharmaceutical Analytical Testing Outsourcing Market (2026 - 2033)

The global pharmaceutical analytical testing outsourcing market size was estimated at USD 9.7 billion in 2025 and is projected to grow from USD 10.6 billion in 2026 to USD 18.6 billion by 2033, growing at a CAGR of 8.5% from 2026 to 2033. North America dominated the market with the large... Read More »

June 2026

Immunotherapy Drugs Market (2026 - 2033)

The global immunotherapy drugs market size was valued at USD 285.7 billion in 2025 and is projected to grow from USD 317.2 billion in 2026 to USD 676.0 billion by 2033, at a CAGR of 11.4% from 2026 to 2033. The market in North America dominated with a revenue share of 41.8% in 2025. ... Read More »

June 2026

Hormone Replacement Therapy Market (2026 - 2033)

The global hormone replacement therapy market size was valued at USD 25.2 billion in 2025 and is projected to grow from USD 26.9 billion in 2026 to USD 39.4 billion by 2033, at a CAGR of 5.6% from 2026 to 2033. North America held the largest market share of 38.6% in 2025. The hormone rep... Read More »

June 2026

Astaxanthin Market (2026 - 2033)

The global astaxanthin market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.3 billion in 2026 to USD 4.3 billion by 2033, at a CAGR of 9.5% from 2026 to 2033. The North America held the largest share of 35.0% of the global market in 2025. The growing dema... Read More »

June 2026

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Vitamins & Minerals), By Stage Type (Adult, Pediatric), By Indication, By Sales Channel (Online, Retail), By Region, And Segment Forecasts, 2026 - 2033

The global parenteral nutrition market size was valued at USD 7.9 billion in 2025 and is projected to grow from USD 8.4 billion in 2026 to USD 12.6 billion by 2033, at a CAGR of 5.9% from 2026 to 2033. The North America held the largest share of 42.2% of the global market in 2025. This growth is attributed to the ri... Read More »

June 2026

Pharmacy Market (2026 - 2033)

The global pharmacy market size was valued at USD 1.4 trillion in 2025 and is projected to grow from USD 1.5 trillion in 2026 to USD 2.6 trillion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The market in North America dominated with a revenue share of 53.1% in 2025. The gr... Read More »

June 2026

Lyme Disease Market (2026 - 2033)

The global lyme disease market size was valued at USD 2.9 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 5.8 billion by 2033, growing at a CAGR of 9.4% from 2026 to 2033. North America Lyme Disease market held the largest share of 43.5% of the global market in 2025. The market is experi... Read More »

June 2026

Long-acting Injectables Therapeutics Market Size, Share & Trends Analysis Report By Therapeutic Area (Infectious Diseases, Metabolic & Endocrine Disorders, Oncology), By Molecule Type, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

The global long-acting injectables therapeutics market size was valued at USD 18.3 billion in 2025 and is projected to grow from USD 20.5 billion to USD 47.7 billion by 2033, at a CAGR of 12.8% from 2026 to 2033. North America held the largest share of 41.8% of the global market in 2025.... Read More »

June 2026

GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Semaglutide (Ozempic, Wegovy, Rybelsus), Tirzepatide), By Application, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

The global GLP-1 receptor agonist market size was valued at USD 66.4 billion in 2025 and is projected to grow from USD 82.0 billion in 2026 to USD 185.3 billion by 2033, at a CAGR of 12.4% from 2026 to 2033. The North America held the largest share of 75.5% of the global market in 2025. GLP-1 receptor agonists have ... Read More »

June 2026

Antibiotic Resistance Market Size, Share & Trends Analysis Report By Disease (cUTI, cIAI, ABSSSI, HABP, CABP, BSI), By Pathogen (E.coli), By Drug Class (Oxazolidinones), By Mechanism Of Action, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

The global antibiotic resistance market size was valued at USD 9.7 billion in 2025 and is projected to grow from USD 10.2 billion in 2026 to USD 14.3 billion by 2033, at a CAGR of 4.9% from 2026 to 2033. The market in North America dominated with a revenue share of 36.5% in 2025. Increas... Read More »

June 2026

HPV Associated Disorders Market Size, Share & Trends Analysis Report By Type (Anal Cancer, Genital Warts), By Treatment (Vaccines, Anti-viral Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2026 - 2033

The global HPV associated disorders market size was valued at USD 19.4 billion in 2025 and is projected to grow from USD 20.4 billion to USD 28.5 billion by 2033, at a CAGR of 4.9% from 2026 to 2033. North America HPV associated disorders market held the largest share of 37.4% of the glo... Read More »

June 2026

India GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Semaglutide, Tirzepatide, Dulaglutide), By Application (Type 2 Diabetes Mellitus, Cardiovascular Risk), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2026 - 2033

The India GLP-1 receptor agonist market size was valued at USD 150.8 million in 2025 and is projected to grow from USD 240.5 million in 2026 to USD 1,004.9 million by 2033, at a CAGR of 22.7% from 2026 to 2033. The market is witnessing strong expansion, driven by the rising prevalence of... Read More »

June 2026